Pathophysiology

Pathophysiology Study Guide

©2018 of 131 Auto-Immunity Disease ............................................................................................................................................................... 32 Hypersensitivity Reactions ........................................................................................................................................................ 34 Immunization/Vaccination ........................................................................................................................................................ 35 Immuno-Compromised Host ..................................................................................................................................................... 36 Transplantation Reactions ......................................................................................................................................................... 37 2.5 Alterations in the Hematological System......................................................................................................... 38 Disorders of Red Blood Cells ..................................................................................................................................................... 39 Disorders of the White Blood Cells ......................................................................................................................................... 39 Disorder of Platelets...................................................................................................................................................................... 42 Disorders of Plasma and Metastasis....................................................................................................................................... 42 Chapter Two Practice Exam ......................................................................................................................................... 45 Chapter 3: The Cardiovascular System........................................................................................................46 3.1 Cardiac Excitation/Rhythmic Disturbances.................................................................................................... 46 Action Potentials............................................................................................................................................................................. 46 Disorders of Conduction.............................................................................................................................................................. 46 Enhanced Automaticity................................................................................................................................................................ 47 Reentry ............................................................................................................................................................................................... 48 Abnormal Conduction Pathways ............................................................................................................................................. 48 3.2 Valvular Function/Dysfunction........................................................................................................................... 49 Mitral Stenosis/Regurgitation .................................................................................................................................................. 49 Aortic Stenosis/Regurgitation .................................................................................................................................................. 49 Tricuspid/Pulmonic Disease ..................................................................................................................................................... 50 3.3 Cardiac Mechanisms/Heart Failure................................................................................................................... 50 Congestive Heart Failure............................................................................................................................................................. 50 Cardiogenic Shock.......................................................................................................................................................................... 52 Transplant ......................................................................................................................................................................................... 52 3.4 Atherosclerosis.......................................................................................................................................................... 53 Risk Factors ...................................................................................................................................................................................... 53 Vascular Disease ............................................................................................................................................................................. 53 Coronary Artery Disease ............................................................................................................................................................. 54 3.5 Hypertension.............................................................................................................................................................. 56 Renin-Angiotensin-Aldosterone System............................................................................................................................... 56 Risk Factors ...................................................................................................................................................................................... 56 Classification .................................................................................................................................................................................... 57 End Organ Effects ........................................................................................................................................................................... 57 3.6 Congenital Heart Disease....................................................................................................................................... 58 Acyanotic Defects ........................................................................................................................................................................... 58 Cyanotic Defects.............................................................................................................................................................................. 58 3.7 Pericardial Disease .................................................................................................................................................. 59 Effusion............................................................................................................................................................................................... 59 Pericarditis........................................................................................................................................................................................ 59 3.8 Peripheral Vascular Disease................................................................................................................................. 60 Arterial................................................................................................................................................................................................ 60 Achieve Page 4